Serious Game for Parkinson's Disease Patients

Parkinson's Disease Clinical Trial

— PARKGAME  

Official title:

Feasibility and Acceptability Study of Serious Game Rehabilitation Program in Parkinson's Disease Patients With Resistant Gait and Balance Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02469350
• Other study ID #: C15-12
• Secondary ID: RCB
• Status: Completed
• Phase: N/A
• First received: May 28, 2015
• Last updated: October 31, 2017
• Start date: June 2015
• Est. completion date: October 4, 2017

Study information

• Verified date: October 2017
• Source: Institut National de la Santé Et de la Recherche Médicale, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study the investigators aim to assess the feasibility and acceptability of a serious game to rehabilitate gait and balance disorders in 10 patients with Parkinson's disease previously operated for deep brain stimulation of the sub thalamic nucleus.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: October 4, 2017
• Est. primary completion date: May 4, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Parkinson's disease

• Gait and balance disorders

• Chronic bilateral deep brain stimulation of the subthalamic nucleus (> 1 year).

Exclusion Criteria:

• Dementia

• Ongoing severe medical condition that prevented assessments

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Intervention

Other:
• Serious game
Rehabilitation with serious game

Locations

Country	Name	City	State
France	ICM, CIC Neurosciences	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Institut National de la Santé Et de la Recherche Médicale, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility questionnaire	self-assessment questionnaire	once a week
Secondary	Acceptability questionnaire	self-assessment questionnaire	once a week
Secondary	biomechanical parameters of gait and balance	recordings of centres of foot and mass displacements and velocities	at inclusion, 3 weeks, 6 weeks and 18 weeks
Secondary	kinematics parameters of gait and balance	range of motion of hip, knee and ankle angles	at inclusion, 3 weeks, 6 weeks and 18 weeks